Titas Banerjee

Titas Banerjee practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Titas Banerjee's NPI, 1659807931, was assigned on May 5, 2017. Titas Banerjee holds Oregon license MD197727.

Titas Banerjee's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

Titas Banerjee's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Titas Banerjee is also affiliated with Adventist Health Portland. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Titas Banerjee to 1 more hospital, 1 clinical lab and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Titas Banerjee practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Titas Banerjee's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Titas Banerjee is licensed in Oregon.

CMS data shows 204 Medicare services from Titas Banerjee across 4 procedure codes in 2024, for 82 Medicare patients. Medicare paid $11,584 for them.

CMS counts 82 Medicare patients who saw Titas Banerjee in 2024. The largest group is 65 to 74, with 38 patients. 59% of them have high blood pressure, and 54% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Titas Banerjee's median patient age at 73, with 52% women.

In 2024, Titas Banerjee wrote 281 Medicare Part D claims for 69 patients. 79% of them were for generic drugs. CMS names the drug for 131 of them, across 9 drugs with 11 or more claims each, at $295,024 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Titas Banerjee for performance year 2024, reported through an alternative payment model (APM). Titas Banerjee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Titas Banerjee as offering telehealth.

Dmand AI links 5 papers to Titas Banerjee, published from 2018 to 2023. The most frequent topics are Immunotherapy, Adoptive, Lymphoma, Mantle-Cell and Lymphoma, Non-Hodgkin. Titas Banerjee has published most often in Leuk Lymphoma. Titas Banerjee's most frequent co-authors are Andy I. Chen, MD, PhD, Laura M. Calvi, MD and Richard Thomas Maziarz, MD.